SCHEMBL23969465

SCHEMBL23969465

C#CCN(Cc1ccc(F)cc1)c1ccc(NCCCOC)cc1

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.49
CYP2C8 P10632 1/20 0.49
CYP2B6 P20813 1/20 0.49
KCNQ4 P56696 4/20 0.47
KCNQ5 Q9NR82 3/20 0.47
KCNQ2 O43526 1/20 0.45
PYCR1 P32322 3/20 0.44
HTR2A P28223 1/20 0.38
ALDH1A1 P00352 1/20 0.36
KCNH3 Q9ULD8 1/20 0.36
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
KMT2A Q03164 1/20 0.35
CACNA1B Q00975 1/20 0.34
NAMPT P43490 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18600155 0.80 PYCR1 (0.53) CYP1A2CYP2C8CYP2B6KCNQ4KCNQ5
SCHEMBL15996890 0.79 CYP1A2 (0.72) CYP1A2CYP2C8CYP2B6KCNQ4KCNQ5
SCHEMBL18575368 0.79 KCNQ4 (0.59) CYP1A2CYP2C8CYP2B6KCNQ4KCNQ5
SCHEMBL15997126 0.79 KCNQ4 (0.53) CYP1A2CYP2C8CYP2B6KCNQ4KCNQ5
SCHEMBL18575369 0.78 ALDH1A1 (0.61) CYP1A2CYP2C8CYP2B6KCNQ4KCNQ5
SCHEMBL18600345 0.76 CYP1A2 (0.59) CYP1A2CYP2C8CYP2B6KCNQ4KCNQ5
SCHEMBL18600161 0.75 CYP1A2 (0.58) CYP1A2CYP2C8CYP2B6KCNQ4KCNQ5
SCHEMBL30494445 0.74 KCNQ4 (0.60) CYP1A2CYP2C8CYP2B6KCNQ4KCNQ5
SCHEMBL15996884 0.74 KCNQ4 (0.78) CYP1A2CYP2C8CYP2B6KCNQ4KCNQ5
SCHEMBL20159076 0.73 KCNQ4 (0.56) CYP1A2CYP2C8CYP2B6KCNQ4KCNQ5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3138833-B1 NOVEL KCNQ POTASSIUM CHANNEL AGONIST, AND PREPARATION METHOD THEREFOR AND USE THEREOF SHANGHAI INST MATERIA MEDICA CAS (CN) 2021-11-03 EP disclosed